BIOMAT Database Logo BIOMAT Database Logo

Low-dose terlipressin plus banding ligation versus low-dose terlipressin alone in the prevention of very early rebleeding of oesophageal varices. 2009

G-H Lo, and W-C Chen, and H-M Wang, and C-K Lin, and H-H Chan, and W-L Tsai, and L-C Cheng, and H-C Yu, and F-W Tsay
Digestive Center, E-DA Hospital, Division of Gastroenterology, Department of Medicine, Kaohsiung Veterans General Hospital, I-Shou University, Taipei, Taiwan. ghlo@kimo.com

BACKGROUND Very early rebleeding is frequently encountered in patients with acute oesophageal variceal bleeding. A trial was designed to assess the efficacy and safety in patients with no active bleeding at endoscopy, receiving banding ligation association with terlipressin to prevent very early rebleeding. METHODS Patients with no active variceal bleeding at endoscopy were evaluated. Eligible patients were randomised to receive terlipressin infusion alone for 5 days (Terlipressin group) or banding ligation plus terlipressin infusion for 2 days (Combined group). Primary endpoints were treatment failure and very early rebleeding. RESULTS The terlipressin group was composed of 46 patients and the Combined group was composed of 47 patients. Both groups were comparable in terms of baseline data. Forty-eight-hour haemostasis was achieved in 91% in the Terlipressin group and 98% in the Combined group (p = 0.20). Very early rebleeding within 48-120 h occurred in 7 patients (15%) in the Terlipressin group but not in any patients (0%) in the Combined group (p = 0.006). Treatment failure was 24% in the Terlipressin group and 2% in the Combined group (p = 0.002). Multivariate analysis revealed that treatment (OR 0.081; 95% CI 0.010 to 0.627) was the only predictive factor of very early rebleeding. Blood requirement was significantly lower in the Combined group than in the Terlipressin group. Complications and 6-week survival were similar in both groups. CONCLUSIONS Combination of banding ligation and terlipressin infusion for 2 days was superior to only infusion of terlipressin for 5 days in the reduction of very early rebleeding and treatment failure in patients with inactive variceal bleeding at endoscopy. BACKGROUND ISRCTN28353453.

UI MeSH Term Description Entries
D008026 Ligation Application of a ligature to tie a vessel or strangulate a part. Ligature,Ligations,Ligatures
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008236 Lypressin The porcine antidiuretic hormone (VASOPRESSINS). It is a cyclic nonapeptide that differs from ARG-VASOPRESSIN by one amino acid, containing a LYSINE at residue 8 instead of an ARGININE. Lys-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE. Lysine Vasopressin,Vasopressin, Lysine,8-Lysine Vasopressin,Diapid,Lys-Vasopressin,Lysyl Vasopressin,Postacton,8 Lysine Vasopressin,Lys Vasopressin,Vasopressin, 8-Lysine,Vasopressin, Lysyl
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004724 Endoscopy Procedures of applying ENDOSCOPES for disease diagnosis and treatment. Endoscopy involves passing an optical instrument through a small incision in the skin i.e., percutaneous; or through a natural orifice and along natural body pathways such as the digestive tract; and/or through an incision in the wall of a tubular structure or organ, i.e. transluminal, to examine or perform surgery on the interior parts of the body. Endoscopic Surgical Procedures,Surgical Procedures, Endoscopic,Endoscopic Surgical Procedure,Endoscopy, Surgical,Surgical Endoscopy,Surgical Procedure, Endoscopic,Procedure, Endoscopic Surgical,Procedures, Endoscopic Surgical
D004932 Esophageal and Gastric Varices Dilated blood vessels in the ESOPHAGUS or GASTRIC FUNDUS that shunt blood from the portal circulation (PORTAL SYSTEM) to the systemic venous circulation. Often they are observed in individuals with portal hypertension (HYPERTENSION, PORTAL). Esophageal Varices,Gastric Varices,Esophageal Varix,Gastric Varix,Varices, Esophageal,Varices, Gastric,Varix, Esophageal,Varix, Gastric
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006471 Gastrointestinal Hemorrhage Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Hematochezia,Hemorrhage, Gastrointestinal,Gastrointestinal Hemorrhages,Hematochezias

Related Publications

G-H Lo, and W-C Chen, and H-M Wang, and C-K Lin, and H-H Chan, and W-L Tsai, and L-C Cheng, and H-C Yu, and F-W Tsay
Meta-analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices.
May 2012, Alimentary pharmacology & therapeutics,
G-H Lo, and W-C Chen, and H-M Wang, and C-K Lin, and H-H Chan, and W-L Tsai, and L-C Cheng, and H-C Yu, and F-W Tsay
Prevention of early variceal rebleeding adding banding to terlipressin therapy.
September 2009, Gut,
G-H Lo, and W-C Chen, and H-M Wang, and C-K Lin, and H-H Chan, and W-L Tsai, and L-C Cheng, and H-C Yu, and F-W Tsay
Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults.
August 2012, The Cochrane database of systematic reviews,
G-H Lo, and W-C Chen, and H-M Wang, and C-K Lin, and H-H Chan, and W-L Tsai, and L-C Cheng, and H-C Yu, and F-W Tsay
Prevention of rebleeding from oesophageal-gastric varices.
April 2001, European journal of gastroenterology & hepatology,
G-H Lo, and W-C Chen, and H-M Wang, and C-K Lin, and H-H Chan, and W-L Tsai, and L-C Cheng, and H-C Yu, and F-W Tsay
Endoscopic banding ligation treatment for bleeding oesophageal varices.
September 1996, Annals of the Academy of Medicine, Singapore,
G-H Lo, and W-C Chen, and H-M Wang, and C-K Lin, and H-H Chan, and W-L Tsai, and L-C Cheng, and H-C Yu, and F-W Tsay
Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices.
August 1993, Lancet (London, England),
G-H Lo, and W-C Chen, and H-M Wang, and C-K Lin, and H-H Chan, and W-L Tsai, and L-C Cheng, and H-C Yu, and F-W Tsay
Controlled trial of terlipressin ('Glypressin') versus vasopressin in the early treatment of oesophageal varices.
July 1982, Lancet (London, England),
G-H Lo, and W-C Chen, and H-M Wang, and C-K Lin, and H-H Chan, and W-L Tsai, and L-C Cheng, and H-C Yu, and F-W Tsay
Incidence and predictors of rebleeding after band ligation of oesophageal varices.
January 2014, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology,
G-H Lo, and W-C Chen, and H-M Wang, and C-K Lin, and H-H Chan, and W-L Tsai, and L-C Cheng, and H-C Yu, and F-W Tsay
. . . and the bands play on. Variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices.
February 1994, Hepatology (Baltimore, Md.),
G-H Lo, and W-C Chen, and H-M Wang, and C-K Lin, and H-H Chan, and W-L Tsai, and L-C Cheng, and H-C Yu, and F-W Tsay
Sclerotherapy versus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices: a randomised study.
May 1996, Gut,
Copied contents to your clipboard!